ISIN | IE00BX7RQY03 |
---|---|
Valor Number | 29134622 |
Bloomberg Global ID | UBUR GR |
Fund Name | UBS (Irl) ETF plc - Factor MSCI USA Low Volatility UCITS ETF (USD) A-dis |
Fund Provider | UBS Asset Management (UK) Ltd |
Fund Provider | UBS Asset Management (UK) Ltd |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity United States |
Distribution Policy | Distribution |
Home Country | Ireland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The objective of the Fund is to seek to track the alternatively weighted equity market performance of the US market. The investment policy of the Fund is to seek to track the performance of the MSCI USA Select Dynamic 50% Risk Weighted Index (Net Return) (or any other index determined by the Directors from time to time to track substantially the same market as the MSCI USA Select Dynamic 50% Risk Weighted Index (Net Return) and which is considered by the Directors to be an appropriate index for the Fund to track), in accordance with the Prospectus (the "Index") as closely as possible, while seeking to minimise as far as possible the difference in performance between the Fund and the Index. |
Peculiarities |
Current Price * | 33.81 USD | 08.05.2025 |
---|---|---|
Previous Price * | 33.94 USD | 07.05.2025 |
52 Week High * | 34.64 USD | 03.03.2025 |
52 Week Low * | 29.19 USD | 29.05.2024 |
NAV * | 33.81 USD | 08.05.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 46,396,621 | |
Unit/Share Assets *** | 41,899,610 | |
Trading Information SIX |
YTD Performance | +4.89% |
31.12.2024 - 08.05.2025
31.12.2024 08.05.2025 |
---|---|---|
YTD Performance (in CHF) | -3.93% |
31.12.2024 - 08.05.2025
31.12.2024 08.05.2025 |
1 month | +7.14% |
08.04.2025 - 08.05.2025
08.04.2025 08.05.2025 |
3 months | +1.49% |
10.02.2025 - 08.05.2025
10.02.2025 08.05.2025 |
6 months | +0.76% |
08.11.2024 - 08.05.2025
08.11.2024 08.05.2025 |
1 year | +13.49% |
08.05.2024 - 08.05.2025
08.05.2024 08.05.2025 |
2 years | +25.61% |
08.05.2023 - 08.05.2025
08.05.2023 08.05.2025 |
3 years | +29.79% |
09.05.2022 - 08.05.2025
09.05.2022 08.05.2025 |
5 years | +76.17% |
08.05.2020 - 08.05.2025
08.05.2020 08.05.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Coca-Cola Co | 1.10% | |
---|---|---|
Johnson & Johnson | 1.02% | |
Republic Services Inc | 1.00% | |
Colgate-Palmolive Co | 0.93% | |
Berkshire Hathaway Inc Class B | 0.89% | |
Keurig Dr Pepper Inc | 0.86% | |
CME Group Inc Class A | 0.85% | |
Consolidated Edison Inc | 0.84% | |
Procter & Gamble Co | 0.83% | |
Yum Brands Inc | 0.82% | |
Last data update | 05.05.2025 |
TER | 0.18% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.18% |
Ongoing Charges *** | 0.18% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |